Skip to content
Shares of the vaccine maker Moderna (MRNA) are up by double digits in after-hours session Tuesday, thanks to a positive clinical update for its experimental coronavirus vaccine mRNA-1273. "Phase 1 data demonstrate that vaccination with mRNA-1273 elicits a robust immune response across all dose levels and clearly support the choice of 100 µg in a prime and boost regimen as the optimal dose for the Phase 3 study,” said Tal Zaks, Chief Medical Officer of Moderna.Following Moderna’s massive gains so far this year, 333% to be exact, is now the right time to recommend investors snap up shares? Jefferies analyst Michael Yee has an almost Schwarzenegger-ish answer to such a question: “We take a stand: If it works, stock will be going up.”To this end, Yee initiated coverage on MRNA with a Buy rating. However, his $90 price target implies a modest 5% upside from current levels. (To watch Yee’s track record, click...
Stock futures opened higher Tuesday evening after newly published data from Moderna fueled hopes that a vaccine providing protection against Covid-19 would be developed in the relative near-term....
Jul.14 -- President Donald Trump says he issued an order to withdraw Hong Kong’s special status with the U.S. and signed legislation that would sanction Chinese officials responsible for cracking down on political dissent in Hong Kong. He spoke in the Rose Garden at the White House....
On Wall Street, some things never change. Public health crisis or not, the fact of the matter remains that healthcare stocks are the epitome of risk/reward plays. Why? It comes down to the nature of the industry itself. Healthcare companies are unique in that their financial performances aren’t necessarily the most important piece of the puzzle. Rather, a few key factors like clinical data readouts or regulatory approvals indicate whether or not a particular name will be able to generate sustainable revenues in the long run. As such, any development, good or bad, can act as a catalyst that launches shares in either direct. So, which strategy can help investors find the healthcare stocks poised to blast off on an upward trajectory? One approach is to follow the pros on Wall Street.We used TipRanks’ database to lock in on three healthcare stocks that have been given the Street’s blessing, and come...
Gleason’s Gym has been a home for boxers since 1937, seeing the likes of Cassius Clay, Jake LaMotta, and Mike Tyson go through its doors. Bruce Silverglade, Gleason’s Gym President, joins The Final Round to discuss how his gym has fared amid the coronavirus pandemic and the struggles it currently faces as reopenings see a rise in new cases. ...
Manufacturers and suppliers now subscribe to the Product Information Exchange Standard (PIES), developed exclusively for heavy-duty parts and components. ...
